Researchers are developing a two-part therapy for type 1 diabetes: lab-made insulin-producing cells paired with custom-engineered immune cells that protect them. The goal is to stop the immune system from destroying transplanted cells — without using immunosuppressive drugs. Backed by $1 million in funding, the team hopes to create a ready-to-use treatment that could work even for people who have had diabetes for years. The approach could transform how the disease is treated.
Quelle: ScienceDaily | Allergy
Titelbild/Grafik: ScienceDaily News
Weiteres von ScienceDaily | Allergy
- Scientists discover spice synergy that boosts anti-inflammation 100x
- Scientists discover why flu and COVID hit older adults so hard
- This common vaccine cuts heart risk nearly in half in new study
- The surprising cancer link between cats and humans
- He survived 48 hours without lungs and lived
- DNA origami vaccines could be the next leap beyond mRNA
- Scientists inject one tumor and watch cancer vanish across the body
- A lab mistake at Cambridge reveals a powerful new way to modify drug molecules
- Severe COVID or flu may raise lung cancer risk years later
- Parents’ stress may be quietly driving childhood obesity, Yale study finds
Möchten Sie zu diesem Inhalt ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!
